Growing community of inventors

Towaco, NJ, United States of America

Kim Timothy Arndt

Average Co-Inventor Count = 3.27

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 7

Kim Timothy ArndtAriamala Gopalsamy (1 patent)Kim Timothy ArndtPei-Pei Kung (15 patents)Kim Timothy ArndtMengxiao Shi (1 patent)Kim Timothy ArndtKristina Martha Kutterer (1 patent)Kim Timothy ArndtPaul Anthony Stupple (5 patents)Kim Timothy ArndtFrank Boschelli (2 patents)Kim Timothy ArndtJennifer M Golas (2 patents)Kim Timothy ArndtAnthony Mazurek (1 patent)Kim Timothy ArndtMaximillian Todd Follettie (0 patent)Kim Timothy ArndtLei Chen (0 patent)Kim Timothy ArndtPhilip Michael Tedeschi (0 patent)Kim Timothy ArndtDavid Scott Fruhling (0 patent)Kim Timothy ArndtWenyan Zhong (0 patent)Kim Timothy ArndtKim Timothy Arndt (3 patents)Ariamala GopalsamyAriamala Gopalsamy (34 patents)Pei-Pei KungPei-Pei Kung (15 patents)Mengxiao ShiMengxiao Shi (12 patents)Kristina Martha KuttererKristina Martha Kutterer (8 patents)Paul Anthony StupplePaul Anthony Stupple (5 patents)Frank BoschelliFrank Boschelli (4 patents)Jennifer M GolasJennifer M Golas (2 patents)Anthony MazurekAnthony Mazurek (1 patent)Maximillian Todd FollettieMaximillian Todd Follettie (0 patent)Lei ChenLei Chen (0 patent)Philip Michael TedeschiPhilip Michael Tedeschi (0 patent)David Scott FruhlingDavid Scott Fruhling (0 patent)Wenyan ZhongWenyan Zhong (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Wyeth (3 from 1,309 patents)

2. Pfizer Corporation (4,455 patents)

3. Ctxt Pty Limited (17 patents)


3 patents:

1. 7919625 - 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)

2. 7417148 - 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)

3. 7388016 - Dibenzonaphthyridine derivatives and methods of use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…